Empagliflozin & Metformin Hydrochloride Tablets (EMPAGILM 5/500)

Product Description:

EMPAGILM 5/500 is a combination medication that combines Empagliflozin (5 mg) and Metformin Hydrochloride (500 mg), two highly effective drugs used in the treatment of Type 2 Diabetes Mellitus. This combination offers a dual-action approach to help control blood sugar levels in patients with Type 2 Diabetes, providing enhanced glycemic control while offering additional benefits such as weight loss and cardiovascular protection.

Empagliflozin (5 mg): An SGLT2 inhibitor, Empagliflozin works by reducing glucose reabsorption in the kidneys, which increases the excretion of excess glucose in the urine, helping lower blood sugar levels.
Metformin Hydrochloride (500 mg): A biguanide, Metformin works by reducing the production of glucose in the liver and improving the body’s sensitivity to insulin, helping to control blood sugar levels more effectively.

Together, these two drugs target different mechanisms to help manage blood sugar more effectively and improve overall diabetes management.

Indications: EMPAGILM 5/500 is indicated for the treatment of Type 2 Diabetes Mellitus in adults. It should be used in conjunction with a proper diet and exercise program and may be prescribed alone or in combination with other anti-diabetic medications.

Benefits:

Dual Action for Better Glycemic Control: The combination of Empagliflozin and Metformin helps lower blood sugar levels by increasing glucose excretion through urine (Empagliflozin) and reducing liver glucose production (Metformin).
Weight Loss: Empagliflozin promotes weight loss by encouraging the elimination of glucose through the urine, which is especially beneficial for patients with Type 2 Diabetes.
Cardiovascular Benefits: Empagliflozin has been shown to reduce the risk of cardiovascular events such as heart attacks and strokes in patients with Type 2 Diabetes and established heart disease.
Convenient Combination: The combination of Empagliflozin and Metformin in one tablet reduces the pill burden, making it easier for patients to manage their diabetes treatment regimen.

Usage Instructions: Take one tablet of EMPAGILM 5/500 once or twice daily, as prescribed by your healthcare provider. It is recommended to take the tablet with food to minimize gastrointestinal discomfort. Follow the dosage instructions provided by your doctor and do not exceed the recommended dose.

Precautions:

Kidney Function: EMPAGILM 5/500 should not be used in patients with severe kidney impairment. Kidney function should be monitored regularly during treatment.
Lactic Acidosis: Metformin is associated with a rare but serious condition called lactic acidosis, which can be life-threatening. Symptoms include muscle pain, difficulty breathing, or fatigue. Seek immediate medical attention if these occur.
Dehydration and Low Blood Pressure: Empagliflozin can cause dehydration and low blood pressure due to its diuretic effects. Make sure to drink adequate amounts of fluid during treatment.
Pregnancy and Lactation: Consult your doctor before using EMPAGILM 5/500 during pregnancy or breastfeeding.

Side Effects: Common side effects include:

Gastrointestinal discomfort (nausea, diarrhea)
Urinary tract infections
Increased urination
Genital fungal infections

Serious side effects (though rare) may include:

Lactic acidosis
Kidney problems
Dehydration
Allergic reactions (swelling, rash, difficulty breathing)

Storage: Store EMPAGILM 5/500 at room temperature (15-30°C), in a dry place away from moisture and heat. Keep out of reach of children.

Packaging: EMPAGILM 5/500 is available in blister packs for convenient use and portability.

Conclusion: EMPAGILM 5/500 provides an effective and convenient combination of Empagliflozin and Metformin Hydrochloride, designed to help patients with Type 2 Diabetes Mellitus achieve better glycemic control, manage weight, and reduce cardiovascular risks. Always consult your healthcare provider to ensure that EMPAGILM 5/500 is the right treatment for your diabetes management plan.